Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Tytuł pozycji:

Effectiveness of transdermal nicotine patch in premenopausal female smokers is moderated by within-subject severity of negative affect and physical symptoms.

Tytuł :
Effectiveness of transdermal nicotine patch in premenopausal female smokers is moderated by within-subject severity of negative affect and physical symptoms.
Autorzy :
Chai SH; Department of Preventive Medicine, University of Southern California Keck School of Medicine, 2001 N Soto Street, 312E, Los Angeles, CA, 90032, USA.
Leventhal AM; Department of Preventive Medicine, University of Southern California Keck School of Medicine, 2001 N Soto Street, 312E, Los Angeles, CA, 90032, USA.; Department of Psychology, University of Southern California, Los Angeles, CA, USA.
Kirkpatrick MG; Department of Preventive Medicine, University of Southern California Keck School of Medicine, 2001 N Soto Street, 312E, Los Angeles, CA, 90032, USA.
Eisenlohr-Moul TA; Department of Psychiatry, University of Illinois Chicago, Chicago, IL, USA.
Rapkin AJ; Department of Obstetrics and Gynecology, Center for the Health Sciences, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.
D'Orazio L; Department of Neurology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
Pang RD; Department of Preventive Medicine, University of Southern California Keck School of Medicine, 2001 N Soto Street, 312E, Los Angeles, CA, 90032, USA. .
Pokaż więcej
Źródło :
Psychopharmacology [Psychopharmacology (Berl)] 2020 Jun; Vol. 237 (6), pp. 1737-1744. Date of Electronic Publication: 2020 Mar 10.
Typ publikacji :
Journal Article
Język :
English
Imprint Name(s) :
Original Publication: Berlin, New York, Springer-Verlag.
MeSH Terms :
Tobacco Use Cessation Devices*
Affect/*physiology
Cigarette Smoking/*psychology
Premenopause/*psychology
Smokers/*psychology
Smoking Cessation/*psychology
Administration, Cutaneous ; Adult ; Affect/drug effects ; Cigarette Smoking/drug therapy ; Female ; Humans ; Nicotine/administration & dosage ; Premenopause/drug effects ; Premenopause/physiology ; Smoking Cessation/methods ; Treatment Outcome
References :
Nicotine Tob Res. 2015 Apr;17(4):486-95. (PMID: 25762760)
J Abnorm Psychol. 2018 Oct;127(7):683-694. (PMID: 30070540)
Nicotine Tob Res. 2007 Apr;9(4):493-8. (PMID: 17454704)
Nicotine Tob Res. 2016 May;18(5):1002-11. (PMID: 26446070)
J Obstet Gynecol Neonatal Nurs. 2006 May-Jun;35(3):376-84. (PMID: 16700687)
Lancet Respir Med. 2015 Feb;3(2):131-138. (PMID: 25588294)
J Neuroimmune Pharmacol. 2016 Sep;11(3):471-83. (PMID: 26872457)
Psychol Med. 2020 Apr;50(6):964-972. (PMID: 31010447)
Pain. 2016 Jul;157(7):1373-81. (PMID: 27023418)
Addiction. 2009 Nov;104(11):1941-2. (PMID: 19832791)
Nicotine Tob Res. 2012 May;14(5):621-5. (PMID: 21908458)
Nicotine Tob Res. 2008 Jul;10(7):1245-50. (PMID: 18629735)
Nicotine Tob Res. 2017 May 1;19(5):578-584. (PMID: 28403472)
J Clin Endocrinol Metab. 2012 Oct;97(10):E1871-9. (PMID: 22837188)
Drug Alcohol Depend. 2017 Sep 1;178:485-491. (PMID: 28715776)
Drug Alcohol Depend. 2010 Nov 1;112(1-2):1-8. (PMID: 20561758)
Exp Clin Psychopharmacol. 2013 Aug;21(4):269-76. (PMID: 23834551)
Nicotine Tob Res. 2015 Apr;17(4):407-21. (PMID: 25762750)
Clin Pharmacol Ther. 2006 May;79(5):480-8. (PMID: 16678549)
Exp Clin Psychopharmacol. 2017 Aug;25(4):235-241. (PMID: 28682101)
Psychopharmacology (Berl). 2002 Sep;163(2):194-201. (PMID: 12202966)
Neuropsychopharmacology. 2018 Mar;43(4):828-837. (PMID: 28905874)
Exp Clin Psychopharmacol. 2014 Oct;22(5):373-83. (PMID: 25133506)
Psychopharmacology (Berl). 2014 Jul;231(13):2595-602. (PMID: 24408214)
Nicotine Tob Res. 2017 Mar 1;19(3):273-281. (PMID: 27613893)
Addict Behav. 2009 Jan;34(1):107-11. (PMID: 18818024)
Addict Biol. 2009 Jan;14(1):99-107. (PMID: 18855800)
Nicotine Tob Res. 2000 Aug;2(3):231-41. (PMID: 11082823)
Addiction. 2008 May;103(5):809-21. (PMID: 18412759)
Am J Addict. 2014 May-Jun;23(3):211-7. (PMID: 24724877)
Addict Behav. 2018 Dec;87:82-85. (PMID: 29966963)
Nicotine Tob Res. 2015 Apr;17(4):463-72. (PMID: 25762757)
Am J Psychiatry. 2017 Jan 1;174(1):51-59. (PMID: 27523500)
Curr Addict Rep. 2016 Mar 1;3(1):1-8. (PMID: 27134810)
J Womens Health (Larchmt). 2008 Mar;17(2):293-301. (PMID: 18321181)
Drug Alcohol Depend. 2011 Mar 1;114(1):68-72. (PMID: 20832955)
J Womens Health (Larchmt). 2008 Mar;17(2):287-92. (PMID: 18321180)
Exp Clin Psychopharmacol. 2017 Jun;25(3):216-222. (PMID: 28493744)
J Reprod Med. 1991 Nov;36(11):769-72. (PMID: 1765953)
Addict Behav. 2009 Aug;34(8):632-5. (PMID: 19409710)
Grant Information :
K01 DA040043 United States DA NIDA NIH HHS; R21 DA034768 United States DA NIDA NIH HHS
Contributed Indexing :
Keywords: Female smokers; Negative affect; Pain; Sex differences; Smoking; Transdermal nicotine patch
Substance Nomenclature :
6M3C89ZY6R (Nicotine)
Entry Date(s) :
Date Created: 20200312 Date Completed: 20200929 Latest Revision: 20200929
Update Code :
20201023
PubMed Central ID :
PMC7244386
DOI :
10.1007/s00213-020-05494-z
PMID :
32157328
Czasopismo naukowe
Rationale: Nicotine patches may be less effective in female compared with male smokers. However, it is unknown if negative affect and physical symptoms influence transdermal nicotine patch-related effects on smoking behaviors.
Methods: Eighty-one acutely tobacco-abstinent premenopausal female smokers attended three counter-balanced experimental sessions across the menstrual cycle (early follicular, late follicular, and mid-luteal) and were randomized to patch condition (nicotine [21 mg] vs. placebo [0 mg] transdermal patch). Negative affect and physical symptoms were assessed prior to patch administration. The patch was removed 5 h post-administration, and participants completed a smoking reinstatement task. Multilevel linear models tested associations of patch condition, negative affect and physical symptoms, and their interaction on smoking behavior.
Results: There was a significant patch condition × Negative Affect and Pain symptoms interaction on the number of cigarettes smoked (p < 0.05). When Negative Affect and Pain were lower-than-usual, females administered a nicotine patch smoked significantly fewer cigarettes than females administered a placebo patch (p < .05), but there were no significant patch differences when Negative Affect and Pain were higher-than-usual. There was also a significant patch condition × Negative Affect interaction on time delay. The effects of patch condition on time delay to smoking were greater during sessions in which Negative Affect was higher-than-usual.
Conclusions: Results suggest that among female smokers transdermal nicotine patch effectiveness may interact with negative affect and pain. Understanding and considering female-specific factors that may impact the efficacy of one of the most commonly used cessation medications is important for improving smoking cessation in female smokers.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies